Please login to the form below

Not currently logged in
Email:
Password:

clinical benefit

This page shows the latest clinical benefit news and features for those working in and with pharma, biotech and healthcare.

FDA leaders offer perspective on accelerated approval of Biogen’s Aduhelm

FDA leaders offer perspective on accelerated approval of Biogen’s Aduhelm

In the post, they explained that although evidence from the Aduhelm programme was suggestive of clinical benefit, they came to the conclusion – alongside the FDA’s Peripheral and Central Nervous System ... Advisory Committee – that the trial data

Latest news

More from news
Approximately 1 fully matching, plus 180 partially matching documents found.

Latest Intelligence

  • Patient-centred drug development: how far have we come and what’s next? Patient-centred drug development: how far have we come and what’s next?

    By Jo Fearnhead-Wymbs. Putting the patient at the centre of clinical development’. ... Studies have already shown that drugs developed using patient-centric clinical trials are up to 19% more likely to launch and be more quickly adopted by payers.

  • Alzheimer’s disease: the search for a cure Alzheimer’s disease: the search for a cure

    Not all of the drugs entering clinical trials will go on to benefit patients, so we are increasing the probability of successfully delivering a disease- modifying treatment by targeting disease processes ... We now know that the diseases that cause

  • The search for effective drug treatments for COVID-19 The search for effective drug treatments for COVID-19

    In response to the WHO study, a Gilead spokesperson said that there was “more robust evidence from multiple randomised, controlled studies published in peer-reviewed journals validating the clinical benefit of ... Lastly, the two randomised,

  • Addressing the payer-regulator evidence gap in early-stage cancer Addressing the payer-regulator evidence gap in early-stage cancer

    Baseline survival times are longer in early-stage disease, and other measures of clinical benefit become relevant such as avoidance of recurrence and quality of life. ... Which alternative endpoints can assess clinical benefit in early-stage disease?

  • Alzheimer’s: the search for a cure Alzheimer’s: the search for a cure

    The analysis of the expanded data set for one of the phase 3 trials, EMERGE, linked aducanumab to improvements on a clinical dementia scale. ... The preponderance of the data indicates aducanumab doesn’t provide a clinical benefit,’ Skorney wrote in

More from intelligence
Approximately 0 fully matching, plus 29 partially matching documents found.

Latest appointments

  • Dr Irina Antonijevic joins vasopharm Dr Irina Antonijevic joins vasopharm

    In this role, Dr Antonijevic will be responsible for advancing the clinical development of the cerebrovascular specialist's lead orphan drug candidate, VAS203. ... Not only will we benefit from her clinical capabilities in our ongoing pivotal study of

  • ICON's CEO named chair of ACRO ICON's CEO named chair of ACRO

    Trade body for clinical research organisation elects Ciaran Murray. The global trade body for clinical research organisations has elected ICON's CEO Ciaran Murray as chairman. ... I look forward to continuing the work that ACRO has done in promoting our

  • Industry veteran Louis Nisbet joins Sygnature board Industry veteran Louis Nisbet joins Sygnature board

    The UK-based clinical research organisation (CRO) will benefit from Dr Nisbet's extensive experience in the life sciences industry, which includes spells in research at Roche, Glaxo and SmithKline.

More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 20 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Genesis Research

Genesis Research is an international HEOR and RWE research organization. A leader in evidence strategy, generation and communication, the company...

Latest intelligence

What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:
Securing a future for telehealth with immersive market research insights...
Accelerating patient recruitment in clinical trials with the Clinical Enrolment Managers (CEMs)
How Innovative Trials' global Clinical Enrolment Managers (CEMs) give clinical trial sites the local touch...